Cells are [still] black boxes

Most of the details of how their fundamental components – proteins – interact, co-localize and traffick together to manifest complex functional responses remain hidden from view.  Our mission is to generate the first complete cellular proteome maps with unprecedented detail to reveal disease mechanisms and find new drug targets.

Until now

Prisma is building the new era of high definition spatial proteomics

 Our Technology

Unveiling the Cellular Proteome: A New Era of Biomedical Research

Imagine a world where we can map every protein within a cell, revealing its location and function in stunning detail. This is the future Prisma is building with in situ proteomics, a revolutionary approach that analyzes proteins directly in their native environment.

This video dives into the core concepts behind Prisma's groundbreaking technology. Our innovative platform leverages the power of our OMNI Probe, a novel reagent that binds directly to the n-terminal amino acid of proteins and generates unique fluorescent signatures based on the amino acid side chain and post-translational modifications. Combined with our cutting-edge, light-based sequencing technique, Prisma's platform enables proteome-scale analysis of proteins, whether they reside on a surface or within the intricate world of a cell.

Contact us to find out more information and how we can work together and tackle the final frontier of human biology

Follow us on LinkedIn for the latest

LinkedIn

Our Team

Dr. Andrew Emili, PhD
Co-Founder
Chief Executive Officer

Dr. Aaron Beeler, PhD
Co-Founder
CSO and Head of Chemistry

Dr. Anderson Chen, PhD
Co-Founder
Chief Imaging Technologies Officer

Dr. Jacob LaPorte, PhD
Co-Founder
Chief Business Officer

Dr. Andrew Martin
Scientist I

Dr. Eashita Das
Scientist I

Carl White
Data Scientist

Mitchell Clough
Scientist I

Andrew Chan
Associate Scientist

Landon Kushimi
Associate Data Analyst

Advisors

Dr. Xiaolin Nan, PhD
Knight Cancer Institute, OHSU
Super Resolution Microscopy Expert

Dr. Brigitte Ritter, PhD
Boston University
Cell Biology and Assays Expert

Dr. Mark Crovella, PhD.
Boston Universtiy
Data and Network Sciences Thought Leader

Dr. Amanda Cashin, PhD
Former Global Head & Co-Founder of Illumina Accelerator & Illumina for Startups

investors

Dr. Carlo Rizzuto, PhD
Versant Ventures
Managing Director

Dr. Alex Mayweg, PhD
Versant Ventures
Managing Director